PETAL: A Global T-Cell Lymphoma Consortium
Integrating machine learning and genomics to drive discovery and predict outcomes for newly diagnosed and relapsed/refractory T-cell and NK-cell lymphomas
Multinational Effort for Rare and Aggressive Lymphomas
Connecting oncologists and scientists across the globe to leverage global expertise in tackling these rare and aggressive diseases
Focusing on Diversity and Equity
PETAL focuses on health disparities by including high-, middle- and low-income countries to capture diverse patient populations to help make access to drugs and education equitable. We @ PETAL believe that no patient should be left behind
Paving the way for breakthroughs
Our goal at PETAL is to enable personalized treatments to improve patient lives. This alliance creates an infrastructure for future studies including clinical trials to test novel treatments
PETAL: A Global T-Cell Lymphoma Consortium
Integrating machine learning and genomics to drive discovery and predict outcomes for newly diagnosed and relapsed/refractory T-cell and NK-cell lymphomas
Multinational Effort for Rare and Aggressive Lymphomas
Connecting oncologists and scientists across the globe to leverage global expertise in tackling these rare and aggressive diseases
Focusing on Diversity and Equity
PETAL focuses on health disparities by including high-, middle- and low-income countries to capture diverse patient populations to help make access to drugs and education equitable. We @ PETAL believe that no patient should be left behind
Paving the way for breakthroughs
Our goal at PETAL is to enable personalized treatments to improve patient lives. This alliance creates an infrastructure for future studies including clinical trials to test novel treatments
PETAL: A Global T-Cell Lymphoma Consortium
Integrating machine learning and genomics to drive discovery and predict outcomes for newly diagnosed and relapsed/refractory T-cell and NK-cell lymphomas
Multinational Effort for Rare and Aggressive Lymphomas
Connecting oncologists and scientists across the globe to leverage global expertise in tackling these rare and aggressive diseases
Focusing on Diversity and Equity
PETAL focuses on health disparities by including high-, middle- and low-income countries to capture diverse patient populations to help make access to drugs and education equitable. We @ PETAL believe that no patient should be left behind
Paving the way for breakthroughs
Our goal at PETAL is to enable personalized treatments to improve patient lives. This alliance creates an infrastructure for future studies including clinical trials to test novel treatments
PETAL: A Global T-Cell Lymphoma Consortium
Integrating machine learning and genomics to drive discovery and predict outcomes for newly diagnosed and relapsed/refractory T-cell and NK-cell lymphomas
Multinational Effort for Rare and Aggressive Lymphomas
Connecting oncologists and scientists across the globe to leverage global expertise in tackling these rare and aggressive diseases
Focusing on Diversity and Equity
PETAL focuses on health disparities by including high-, middle- and low-income countries to capture diverse patient populations to help make access to drugs and education equitable. We @ PETAL believe that no patient should be left behind
Paving the way for breakthroughs
Our goal at PETAL is to enable personalized treatments to improve patient lives. This alliance creates an infrastructure for future studies including clinical trials to test novel treatments
PETAL: A Global T-Cell Lymphoma Consortium
Integrating machine learning and genomics to drive discovery and predict outcomes for newly diagnosed and relapsed/refractory T-cell and NK-cell lymphomas
Multinational Effort for Rare and Aggressive Lymphomas
Connecting oncologists and scientists across the globe to leverage global expertise in tackling these rare and aggressive diseases
Focusing on Diversity and Equity
PETAL focuses on health disparities by including high-, middle- and low-income countries to capture diverse patient populations to help make access to drugs and education equitable. We @ PETAL believe that no patient should be left behind
Paving the way for breakthroughs
Our goal at PETAL is to enable personalized treatments to improve patient lives. This alliance creates an infrastructure for future studies including clinical trials to test novel treatments
PETAL: A Global T-Cell Lymphoma Consortium
Integrating machine learning and genomics to drive discovery and predict outcomes for newly diagnosed and relapsed/refractory T-cell and NK-cell lymphomas
Multinational Effort for Rare and Aggressive Lymphomas
Connecting oncologists and scientists across the globe to leverage global expertise in tackling these rare and aggressive diseases
Focusing on Diversity and Equity
PETAL focuses on health disparities by including high-, middle- and low-income countries to capture diverse patient populations to help make access to drugs and education equitable. We @ PETAL believe that no patient should be left behind
Paving the way for breakthroughs
Our goal at PETAL is to enable personalized treatments to improve patient lives. This alliance creates an infrastructure for future studies including clinical trials to test novel treatments
PETAL: A Global T-Cell Lymphoma Consortium
Integrating machine learning and genomics to drive discovery and predict outcomes for newly diagnosed and relapsed/refractory T-cell and NK-cell lymphomas
Multinational Effort for Rare and Aggressive Lymphomas
Connecting oncologists and scientists across the globe to leverage global expertise in tackling these rare and aggressive diseases
Focusing on Diversity and Equity
PETAL focuses on health disparities by including high-, middle- and low-income countries to capture diverse patient populations to help make access to drugs and education equitable. We @ PETAL believe that no patient should be left behind
Paving the way for breakthroughs
Our goal at PETAL is to enable personalized treatments to improve patient lives. This alliance creates an infrastructure for future studies including clinical trials to test novel treatments
PETAL: A Global T-Cell Lymphoma Consortium
Integrating machine learning and genomics to drive discovery and predict outcomes for newly diagnosed and relapsed/refractory T-cell and NK-cell lymphomas
Multinational Effort for Rare and Aggressive Lymphomas
Connecting oncologists and scientists across the globe to leverage global expertise in tackling these rare and aggressive diseases
Focusing on Diversity and Equity
PETAL focuses on health disparities by including high-, middle- and low-income countries to capture diverse patient populations to help make access to drugs and education equitable. We @ PETAL believe that no patient should be left behind
Paving the way for breakthroughs
Our goal at PETAL is to enable personalized treatments to improve patient lives. This alliance creates an infrastructure for future studies including clinical trials to test novel treatments
WHO WE ARE
Our Identity
We are an internationally cohesive group of medical specialists and investigators.
What do we do
We are a global coordinated team of clinical experts and researchers performing genomics and utilizing deep learning tools to correlate with clinical data in a prospective longitudinal study.
Menu
@2024 PETAL Consortium • All rights reserved
Menu
@2024 PETAL Consortium • All rights reserved